Additionally, our study shows that IBTK overexpression suppresses AS-induced SG assembly and that ablation of IBTK sensitizes cancer cells to eIF4A inhibitor-induced cell death, making IBTK a potential therapeutic target to overcome intrinsic resistance to eIF4A inhibitors. Here, IBTK is linked to cancer.